Overview
Corporate Mission Statement
CEO Message
Board of Directors
Key Employees
Corporate History
Awards |
Timeline: |
1983
|
Ash Medical
Systems, Inc (“AMS”)
founded by Dr. Stephen R. Ash and Robert B. Truitt to develop a
home hemodialysis system
|
AMS creates spin off company, HemoCleanse, Inc (“HCI”),
to develop new liver dialysis system and technology
|
1989
|
|
|
1997
|
HemoCleanse, Inc purchases AMS
to consolidate assets and develop vascular access technologies
|
HemoCleanse,
Inc creates spin off company, Renal Solutions, Inc, ("RSI") to
commercialize home hemodialysis system
|
2000
|
|
|
2003
|
AMS is renamed Ash Access
Technology, Inc. and is spun off from HemoCleanse, Inc. in order
to commercialize vascular access technologies
|
Ash
Access Technology, Inc. begins pivotal clinical trial on Zuragen™
|
2006
|
|
|
2007
|
Received FDA approval for Centros™. Strategic partnership for Centros™ initiated with AngioDynamics, Inc.
|
AZEPTIC Trial completed for Zuragen™ Injection. Human "pilot" studies completed with ZuraPrep™
|
|
|
Product Development:
- Column Disc
peritoneal dialysis (PD) catheter
- Y-Tech
peritoneoscopic
system PD
- Cal-Carb HD
oral calcium carbonate, phosphate binder
- SmartChart
electronic clinical notation system
- CFC
capillary filtrate collector,
sub-q catheter
- BioLogic-HD
home hemodialysis system
- BioLogic DT
liver dialysis machine
- ThermoChem-HT
intraperitoneal hyperthermia
system
- Ash Advantage
peritoneal dialysis (PD) catheter
- Ash
Split-Cath
chronic tunneled hemodialysis catheter
- DuoSplit
acute
hemodialysis catheter
- HC-10
high flow single lumen catheter for
liver dialysis
- Allient
home hemodialysis system (by spin-off RSI)
- Centros™
chronic tunneled hemodialysis catheter (strategic commercial partnership with Angiodynamics, Inc.)
|